Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Open-labeled Study of the Safety, Efficacy, and Pharmacokinetics of Lubiprostone in Pediatric Patients With Constipation

NCT00452335 is registered in ClinicalTrials.gov with Sucampo Pharma Americas, LLC as lead sponsor.

NCT NCT00452335
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00452335 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Open-labeled Study of the Safety, Efficacy, and Pharmacokinetics of Lubiprostone in Pediatric Patients With Constipation
Lead sponsor
Sucampo Pharma Americas, LLC
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2007
Completion date
October 31, 2008
Enrollment
127 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

constipation